Кстати, идея проведения холтера всем пациентам с ишемическим инсультом вполне разумна. ФП выявляется достаточно часто, особенно в старшей возрастной группе.
Канада впереди планеты всей....
Цитата:
We suggest, that when OAC therapy is indicated, most patients should receive dabigatran, rivaroxaban, or apixaban (once approved by Health Canada), in preference to warfarin (Conditional Recommendation, High-Quality Evidence).
Values and preferences. This recommendation places a relatively high value on comparisons with warfarin showing that dabigatran and apixaban have greater efficacy and rivaroxaban has similar efficacy for stroke prevention; dabigatran and rivaroxaban have no more major bleeding and apixaban has less; all 3 new OACs have less intracranial hemorrhage and are much simpler to use. The recommendation places less value on the following features of warfarin: long experience with clinical use, availability of a specific antidote, and a simple and standardized test for intensity of anticoagulant effect. The preference for 1 of the new OACs over warfarin is less marked among patients already receiving warfarin with stable INRs and no bleeding complications.
|
Цитата из [
Ссылки доступны только зарегистрированным пользователям ]